Search – Page 33 – Indianapolis Business Journal

Home » Search

Articles

Lilly sees fourth-quarter profit jump 13%, with strong demand for Mounjaro and Zepbound

February 6, 2024 | John Russell

The Indianapolis based drugmaker posted net income of $2.19 billion for the quarter. Excluding nonrecurring items, adjusted earnings per share of $2.49 beat the FactSet consensus of $2.30.

Elanco to sell aqua business to Merck for $1.3B

February 5, 2024 | John Russell

Elanco Animal Health said it has agreed to sell its aqua business to Merck Animal Health, a move that allows it to pay down some of its debt load and invest in new pipeline products.

IU, Lilly roll out co-op partnership to address Indiana’s workforce shortage

February 1, 2024 | John Russell

The partnership will connect undergraduate students and degree programs from the IU Indianapolis campus with opportunities at Lilly, such as finance, human resources and information technology.

BioCrossroads names Vince Wong as new CEO of Indy life sciences group

January 31, 2024 | John Russell

Wong’s appointment comes just a few weeks after BioCrossroads released a report warning that Indiana’s life-science sector is starting to lag the nation in growth and market share and will require a focused effort to stay competitive.

Lawmakers want IEDC to disclose more information

January 26, 2024 | Peter Blanchard

As the Republican-led agency faces calls from critics for more transparency, legislators from both political parties have filed legislation aimed at requiring the job-creation agency to disclose more about its activities.

Lilly factory in New Jersey comes under more federal scrutiny

January 22, 2024 | John Russell

Lilly said it was working closely with the FDA and the “situation does not affect the quality, safety or supply of any current or planned Lilly products in the marketplace.”

Move away from coal could be slowed under Indiana bill

January 18, 2024 | John Russell

State Rep. Cindy Ledbetter introduced the bill this month, saying utilities are moving too fast to retire and replace generating capacity that might be needed as demand for electricity grows.

Brad Chambers brings business acumen to GOP bid for governor

January 12, 2024 | Peter Blanchard

But in a race that has five competitive candidates for the Republican nomination for governor, being a recognizable figure can be just as important as financial prowess, and Chambers has some ground to make up in the recognition category.

Stephen Goldsmith: Mall project is opportunity for downtown’s new start

January 12, 2024 | Stephen Goldsmith

The recent announcement by the city of Indianapolis and the equity owners of Circle Centre Mall that Hendricks Commercial Properties LLC, the developer of the successful Bottleworks District and Ironworks projects, will acquire and invest in the downtown mall is unequivocally good news.

Statehouse Democrats’ agenda targets child care, drug prices, more

January 12, 2024 | Whitney Downard, Indiana Capital Chronicle

Indiana Statehouse Democrats from both the Senate and House came together Thursday afternoon to release a bicameral agenda, which they said underlined their commitment to big-ticket issues even in a short session.

Riley Children’s Foundation sets up nutrition research partnership with $2.5M gift from Lilly CEO’s foundation

January 10, 2024 | John Russell

In addition, the Ricks Family Foundation says it will match up to an additional $2.5 million in donations from individuals, foundations and corporations.

Report: Indiana lagging nation in life sciences sector growth

January 8, 2024 | John Russell

Indiana’s pharmaceutical and medical device sectors, long touted as major contributors to the state’s economy, are starting to lag the nation in growth and market share and will require a focused effort to stay competitive, according to a new report released Monday.

Report: Indianapolis tops Midwestern cities in three-year GDP growth

January 4, 2024 | Taylor Wooten and Mickey Shuey

Indianapolis surpassed its Midwestern peers in gross domestic product growth from 2019 to 2022, according to a report from a Washington, D.C.-based economist.

Lilly launches online service that offers home delivery of weight-loss, diabetes, migraine drugs

January 4, 2024 | IBJ Staff and Bloomberg News

Among the medications listed as available through LillyDirect Pharmacy Services is Zepbound, the company’s popular new weight loss treatment, which is projected to exceed $2 billion in sales in 2024.

Nevada company sues Lilly for breach of contract over Alzheimer’s drug

January 3, 2024 | John Russell

Lilly called the lawsuit “baseless” and said PDL BioPharma “has no plausible claim to royalties” for donanemab, which is expected to be approved by the FDA this quarter.

2023 Newsmaker: Ricks leads Lilly to new heights

December 29, 2023 | John Russell

David Ricks led Eli Lilly and Co. to milestone after milestone in 2023, with a slew of product launches for diseases from obesity to inflammatory bowel disease. And when Lilly wasn’t scoring wins in the laboratory, it was issuing a series of head-turning announcements,

2023 Year in Review: Lilly had a ‘big-deal’ year

December 29, 2023 | Susan Orr

Among other big dealmakers in 2023 was Hillenbrand Inc., Jasper-based Kimball International Inc. and Noblesville-based Helmer Scientific Inc.

2023 Year in Review: LEAP District stirs debate in Indiana communities

December 29, 2023 | Peter Blanchard

The LEAP Research and Innovation District under development near Lebanon represents a shift in the way the Indiana Economic Development Corp., the public-private state agency overseeing the project, is working to attract companies and create jobs.

Q&A: Indy Chamber’s new CEO Matt Mindrum

December 29, 2023 | Peter Blanchard

Matt Mindrum is a month into his new role and recently spoke with IBJ about his vision for the region’s growth, downtown vitality and his new insights into youth apprenticeships.

Legislative push brewing to make new weight loss drugs more accessible

December 29, 2023 | Associated Press

Obesity drugs like Wegovy and Eli Lilly’s Zepbound are showing promising results in helping people shed pounds. But a law bans Medicare from paying for weight loss drugs. Now, drugmakers and a bipartisan coalition of lawmakers are gearing up to push for that to change next year.

« Previous 1 … 31 32 33 34 35 … 221 Next »

Search Results

4,410 results for '\"eli lilly\"'

Articles

Lilly sees fourth-quarter profit jump 13%, with strong demand for Mounjaro and Zepbound

Elanco to sell aqua business to Merck for $1.3B

IU, Lilly roll out co-op partnership to address Indiana’s workforce shortage

BioCrossroads names Vince Wong as new CEO of Indy life sciences group

Lawmakers want IEDC to disclose more information

Lilly factory in New Jersey comes under more federal scrutiny

Move away from coal could be slowed under Indiana bill

Brad Chambers brings business acumen to GOP bid for governor

Stephen Goldsmith: Mall project is opportunity for downtown’s new start

Statehouse Democrats’ agenda targets child care, drug prices, more

Riley Children’s Foundation sets up nutrition research partnership with $2.5M gift from Lilly CEO’s foundation

Report: Indiana lagging nation in life sciences sector growth

Report: Indianapolis tops Midwestern cities in three-year GDP growth

Lilly launches online service that offers home delivery of weight-loss, diabetes, migraine drugs

Nevada company sues Lilly for breach of contract over Alzheimer’s drug

2023 Newsmaker: Ricks leads Lilly to new heights

2023 Year in Review: Lilly had a ‘big-deal’ year

2023 Year in Review: LEAP District stirs debate in Indiana communities

Q&A: Indy Chamber’s new CEO Matt Mindrum

Legislative push brewing to make new weight loss drugs more accessible